| 000 | 01915 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514063153.0 | ||
| 264 | 0 | _c20031204 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0934-0874 | ||
| 024 | 7 |
_a10.1007/s00147-002-0510-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStratta, Robert J | |
| 245 | 0 | 0 |
_aImproving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cMar 2003 |
||
| 300 |
_a154-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xsurgery |
| 650 | 0 | 4 | _aDrainage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPancreas Transplantation _ximmunology |
| 650 | 0 | 4 |
_aPortal System _xsurgery |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReoperation _xstatistics & numerical data |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLo, Agnes | |
| 700 | 1 | _aShokouh-Amiri, M Hosein | |
| 700 | 1 | _aEgidi, M Francesca | |
| 700 | 1 | _aGaber, Lillian W | |
| 700 | 1 | _aGaber, A Osama | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 16 _gno. 3 _gp. 154-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00147-002-0510-1 _zAvailable from publisher's website |
| 999 |
_c12457582 _d12457582 |
||